About DexCom, Inc. (DXCM)

Company Description:

DexCom, Inc. specializes in the development, manufacture, and distribution of continuous glucose monitoring systems for diabetes management. Its products are designed to help patients control their diabetes by tracking glucose levels in real-time.

The company was founded in 1999 and is headquartered in San Diego, California, United States. It has revolutionized diabetes care with its innovative glucose monitoring technology.

Main Product(s):

DexCom's primary product is the continuous glucose monitoring (CGM) system, which includes a sensor for detecting glucose levels, a transmitter that sends data to a display device, and a receiver or compatible smart device that displays glucose information.

Short History of DexCom, Inc:

• 1999 – DexCom was founded.
• 2005 – FDA approved the first DexCom Continuous Glucose Monitoring System.
• 2012 – Introduction of the G4 PLATINUM CGM System.
• 2015 – Launch of the G5 Mobile CGM System, allowing remote monitoring.
• 2018 – Release of the G6 CGM System, featuring a 10-day wear sensor and no required fingersticks.
• 2020 – Collaboration with Insulet Corporation to develop an integrated CGM system.